BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue W, Wang P, Tu G, Yang F, Zheng G, Li X, Li X, Chen Y, Yao X, Zhu F. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder. Phys Chem Chem Phys 2018;20:6606-16. [DOI: 10.1039/c7cp07869b] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Hellsberg E, Ecker GF, Stary-Weinzinger A, Forrest LR. A structural model of the human serotonin transporter in an outward-occluded state. PLoS One 2019;14:e0217377. [PMID: 31251747 DOI: 10.1371/journal.pone.0217377] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Hong J, Luo Y, Zhang Y, Ying J, Xue W, Xie T, Tao L, Zhu F. Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning. Brief Bioinform 2020;21:1437-47. [PMID: 31504150 DOI: 10.1093/bib/bbz081] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
3 Fu J, Tang J, Wang Y, Cui X, Yang Q, Hong J, Li X, Li S, Chen Y, Xue W, Zhu F. Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification. Front Pharmacol 2018;9:681. [PMID: 29997509 DOI: 10.3389/fphar.2018.00681] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
4 Yang Q, Wang Y, Zhang S, Tang J, Li F, Yin J, Li Y, Fu J, Li B, Luo Y, Xue W, Zhu F. Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools. Int J Mol Sci 2019;20:E151. [PMID: 30609812 DOI: 10.3390/ijms20010151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
5 Li XX, Yin J, Tang J, Li Y, Yang Q, Xiao Z, Zhang R, Wang Y, Hong J, Tao L, Xue W, Zhu F. Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target. Front Pharmacol 2018;9:1245. [PMID: 30429792 DOI: 10.3389/fphar.2018.01245] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
6 Wang P, Jing C, Yu P, Lu M, Xu X, Pei Q, Yan F. Profiling the structural determinants of aminoketone derivatives as hNET and hDAT reuptake inhibitors by field-based QSAR based on molecular docking. Technol Health Care 2021;29:257-73. [PMID: 33682763 DOI: 10.3233/THC-218024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xue W, Fu T, Deng S, Yang F, Yang J, Zhu F. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram. ACS Chem Neurosci 2022. [PMID: 35041375 DOI: 10.1021/acschemneuro.1c00694] [Reference Citation Analysis]
8 Zhang Y, Fu T, Ren Y, Li F, Zheng G, Hong J, Yao X, Xue W, Zhu F. Selective Inhibition of HDAC1 by Macrocyclic Polypeptide for the Treatment of Glioblastoma: A Binding Mechanistic Analysis Based on Molecular Dynamics. Front Mol Biosci 2020;7:41. [PMID: 32219100 DOI: 10.3389/fmolb.2020.00041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li YH, Li XX, Hong JJ, Wang YX, Fu JB, Yang H, Yu CY, Li FC, Hu J, Xue WW, Jiang YY, Chen YZ, Zhu F. Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs. Brief Bioinform 2020;21:649-62. [PMID: 30689717 DOI: 10.1093/bib/bby130] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 40.0] [Reference Citation Analysis]
10 Han ZJ, Xue WW, Tao L, Zhu F. Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis. CNS Neurosci Ther 2018;24:1253-63. [PMID: 30106219 DOI: 10.1111/cns.13051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
11 Zhang S, Lv S, Fu X, Han L, Han W, Li W. Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates. Molecules 2021;26:6492. [PMID: 34770898 DOI: 10.3390/molecules26216492] [Reference Citation Analysis]
12 Fu TT, Tu G, Ping M, Zheng GX, Yang FY, Yang JY, Zhang Y, Yao XJ, Xue WW, Zhu F. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacol Sin 2021;42:1354-67. [PMID: 33122823 DOI: 10.1038/s41401-020-00541-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Tu G, Fu T, Yang F, Yao L, Xue W, Zhu F. Prediction of GluN2B-CT1290-1310/DAPK1 Interaction by Protein⁻Peptide Docking and Molecular Dynamics Simulation. Molecules 2018;23:E3018. [PMID: 30463177 DOI: 10.3390/molecules23113018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Farrokhzadeh A, Akher FB, Egan TJ. Molecular Mechanism Exploration of Potent Fluorinated PI3K Inhibitors with a Triazine Scaffold: Unveiling the Unusual Synergistic Effect of Pyridine-to-Pyrimidine Ring Interconversion and CF3 Defluorination. J Phys Chem B 2021;125:10072-84. [PMID: 34473499 DOI: 10.1021/acs.jpcb.1c03242] [Reference Citation Analysis]
15 Xu L, Chen LY. Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions. Chem Biol Drug Des 2021;97:1194-209. [PMID: 33754484 DOI: 10.1111/cbdd.13841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shen C, Liu H, Wang X, Lei T, Wang E, Xu L, Yu H, Li D, Yao X. Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I1/2 NIK Inhibitors. Front Pharmacol 2019;10:345. [PMID: 31024312 DOI: 10.3389/fphar.2019.00345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Cui X, Yang Q, Li B, Tang J, Zhang X, Li S, Li F, Hu J, Lou Y, Qiu Y, Xue W, Zhu F. Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics. Front Pharmacol 2019;10:127. [PMID: 30842738 DOI: 10.3389/fphar.2019.00127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
18 Chaudhari R, Fong LW, Tan Z, Huang B, Zhang S. An up-to-date overview of computational polypharmacology in modern drug discovery. Expert Opin Drug Discov 2020;15:1025-44. [PMID: 32452701 DOI: 10.1080/17460441.2020.1767063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yu YX, Liu WT, Li HY, Wang W, Sun HB, Zhang LL, Wu SL. Decoding molecular mechanism underlying binding of drugs to HIV-1 protease with molecular dynamics simulations and MM-GBSA calculations. SAR QSAR Environ Res 2021;32:889-915. [PMID: 34551634 DOI: 10.1080/1062936X.2021.1979647] [Reference Citation Analysis]
20 Yang QX, Wang YX, Li FC, Zhang S, Luo YC, Li Y, Tang J, Li B, Chen YZ, Xue WW, Zhu F. Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility. CNS Neurosci Ther 2019;25:1054-63. [PMID: 31350824 DOI: 10.1111/cns.13196] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]